NORTH AMERICA BLOOD PLASMA MARKET FORECAST 2020-2028

NORTH AMERICA BLOOD PLASMA MARKET FORECAST 2020-2028

  • April 2020 •
  • 187 pages •
  • Report ID: 5403216 •
  • Format: PDF
KEY FINDINGS
The North America blood plasma market is estimated to project a CAGR of 6.13% during the forecast period. The region is considered to be a focal point for blood plasma therapy research and development activities, which is further assimilated into various treatment methods of the region.

MARKET INSIGHTS
The North America blood plasma market growth analysis involves the market assessment of Canada and the United States.In Canada, the potential benefits of blood plasma are explored to its fullest by several research organizations in Canada.

The platelet-rich plasma (PRP) therapy has been adopted by the center for treating hair loss as a proactive approach for both male and female patients.The therapy has also proved beneficial for patients that needed hair growth stimulation, and is also a preferred method of treatment among physicians.

There is also an increasing demand for plasmapheresis in the North American region, along with an increasing number of people hemophilic patients in the US, all of which boost the overall growth of the market.

COMPETITIVE INSIGHTS
Some of the bog market players having their presence in the market include, Baxter International, Bio Products Laboratory, Arthrex, Cerus Corporation (Cerus), Biotest AG, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ADMA BIOLOGICS
2. ARTHREX
3. BIO PRODUCTS LABORATORY
4. BAXTER INTERNATIONAL
5. BIOTEST AG
6. CERUS CORPORATION (CERUS)
7. CHINA BIOLOGIC PRODUCTS
8. CSL LIMITED
9. FUSION HEALTH CARE
10. GREEN CROSS HOLDINGS CORPORATION
11. GRIFOLS
12. LFB
13. OCTAPHARMA
14. TAKEDA PHARMACEUTICAL COMPANY
15. KEDRION BIOPHARMA INC